THERALASE TECHNOLOGIES INC (TLT.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:TLT - CA88337V1004 - Common Stock
0.25 CAD
+0.01 (+2.04%)
TLT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 16 industry peers in the Health Care Equipment & Supplies industry. TLT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, TLT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year TLT has reported negative net income.
- In the past year TLT has reported a negative cash flow from operations.
- TLT had negative earnings in each of the past 5 years.
- TLT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -144.90%, TLT is in line with its industry, outperforming 56.25% of the companies in the same industry.
- With a decent Return On Equity value of -398.40%, TLT is doing good in the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -144.9% | ||
| ROE | -398.4% | ||
| ROIC | N/A |
ROA(3y)-132.13%
ROA(5y)-105.29%
ROE(3y)-205.01%
ROE(5y)-152.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TLT has a Gross Margin of 55.35%. This is comparable to the rest of the industry: TLT outperforms 56.25% of its industry peers.
- TLT's Gross Margin has improved in the last couple of years.
- TLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.53%
GM growth 5Y53.42%
2. Health
2.1 Basic Checks
- TLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, TLT has more shares outstanding
- The number of shares outstanding for TLT has been increased compared to 5 years ago.
- TLT has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -16.45, we must say that TLT is in the distress zone and has some risk of bankruptcy.
- TLT has a Altman-Z score of -16.45. This is comparable to the rest of the industry: TLT outperforms 56.25% of its industry peers.
- TLT has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- TLT has a Debt to Equity ratio of 0.19. This is amongst the best in the industry. TLT outperforms 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.45 |
ROIC/WACCN/A
WACC9.16%
2.3 Liquidity
- TLT has a Current Ratio of 0.83. This is a bad value and indicates that TLT is not financially healthy enough and could expect problems in meeting its short term obligations.
- TLT has a Current ratio of 0.83. This is in the better half of the industry: TLT outperforms 68.75% of its industry peers.
- TLT has a Quick Ratio of 0.83. This is a bad value and indicates that TLT is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of TLT (0.57) is better than 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 23.81% over the past year.
- TLT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.45%.
- TLT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.40% yearly.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y9.8%
Revenue growth 5Y1.4%
Sales Q2Q%-19.6%
3.2 Future
- TLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.54% yearly.
- Based on estimates for the next years, TLT will show a very strong growth in Revenue. The Revenue will grow by 256.32% on average per year.
EPS Next Y39.41%
EPS Next 2Y-10.08%
EPS Next 3Y47.54%
EPS Next 5YN/A
Revenue Next Year13.84%
Revenue Next 2Y93.98%
Revenue Next 3Y256.32%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TLT. In the last year negative earnings were reported.
- Also next year TLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- TLT's earnings are expected to grow with 47.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.08%
EPS Next 3Y47.54%
5. Dividend
5.1 Amount
- TLT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
THERALASE TECHNOLOGIES INC / TLT.CA FAQ
What is the ChartMill fundamental rating of THERALASE TECHNOLOGIES INC (TLT.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to TLT.CA.
What is the valuation status for TLT stock?
ChartMill assigns a valuation rating of 1 / 10 to THERALASE TECHNOLOGIES INC (TLT.CA). This can be considered as Overvalued.
What is the profitability of TLT stock?
THERALASE TECHNOLOGIES INC (TLT.CA) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for TLT stock?
The Earnings per Share (EPS) of THERALASE TECHNOLOGIES INC (TLT.CA) is expected to grow by 39.41% in the next year.